Kids "Immunity Gummies": What Elderberry, Echinacea, and Vitamin C Actually Do
Walk down any U.S. drugstore vitamin aisle in cold-and-flu season and the children's section is dominated by gummies promising "immune support." Most combine some mix of vitamin C, zinc, elderberry, echinacea, and occasionally vitamin D. The marketing implies these gummies will keep children from getting sick, recover them faster when they do, or "boost" the immune system in some unspecified way. The pediatric evidence is thinner than the packaging suggests — in some cases, considerably thinner.
Vitamin C: The Cochrane Verdict
The 2013 Hemilä Cochrane review — the gold standard reference, with 29 trials and 11,306 participants — concluded that regular vitamin C supplementation does not prevent colds in the general population. It does shorten cold duration in children by about 14% (one less day per cold for kids on continuous prophylaxis). Starting vitamin C after symptoms begin shows no consistent benefit. The doses studied (200–1,000 mg/day) are higher than what most children's gummies provide.
Echinacea: Unhelpful and Possibly Risky
The largest pediatric trial — Taylor 2003 in JAMA, 524 children with upper respiratory infections — found that Echinacea purpurea did not reduce duration or severity of symptoms versus placebo. It did increase the rate of rash by 7.1% vs 2.7% in the placebo group. Health Canada and the U.K.'s MHRA have advised against echinacea use in children under 12 because of allergic reaction concerns. The 2014 Cochrane review (Karsch-Volk) found echinacea "may have a weak benefit" in adult cold prevention but found insufficient evidence for treatment effects, and explicitly noted that pediatric data did not support pediatric use.
Elderberry: A Mixed Evidence Base
Adult trials of elderberry have suggested a 2–3 day reduction in cold and flu symptom duration. The single high-quality pediatric trial (Macknin 2020 in Clinical Infectious Diseases) randomized 87 children with influenza to elderberry syrup or placebo within 48 hours of symptom onset; the elderberry group showed no benefit and a possibly longer duration of symptoms. Elderberry products in children's gummies typically contain doses well below those used in adult trials. Raw elderberries, leaves, and bark contain cyanogenic glycosides and must not be eaten by children.
Zinc: Lozenges, Not Gummies
The Cochrane review of zinc for the common cold concluded that zinc lozenges started within 24 hours of symptom onset reduce cold duration in adults. The pediatric data are weaker; the 2015 update found insufficient evidence for routine zinc use in children for cold prevention or treatment. Critically, the lozenge form (allowing direct contact with throat tissue) is what shows benefit. Gummies that bypass mouth-and-throat contact via swallowing are unlikely to deliver the lozenge mechanism, and the gummy doses are typically below the 75 mg/day threshold cited in adult lozenge trials.
What Actually Reduces Pediatric Respiratory Infections
Hand washing, influenza vaccination, age-appropriate respiratory virus vaccines (RSV monoclonal for infants), avoidance of secondhand smoke, daycare hygiene policies, breastfeeding for the first six months, and adequate vitamin D status. None of these are immunity gummies. A child who is severely deficient in vitamin D, iron, or zinc will benefit from correcting that specific deficiency — but a "kitchen-sink" gummy is not how pediatricians correct documented deficiencies.
Sugar Content
A typical "immunity" gummy contains 2–5 g of added sugar per serving. Two or three gummies per day in a child during cold season can deliver more added sugar than a small candy bar over a month. The American Heart Association recommends <25 g/day added sugar for children 2–18 and zero added sugar before age 2. Daily gummies push children meaningfully toward those limits with no demonstrated benefit.
Sources
- Hemilä H, Chalker E. "Vitamin C for preventing and treating the common cold." Cochrane Database of Systematic Reviews, 2013;(1):CD000980. PMID 23440782.
- Taylor JA, Weber W, Standish L, et al. "Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial." JAMA, 2003;290(21):2824–2830. PMID 14657066.
- Karsch-Volk M, Barrett B, Kiefer D, et al. "Echinacea for preventing and treating the common cold." Cochrane Database of Systematic Reviews, 2014;(2):CD000530. PMID 24554461.
- Macknin M, Wolski K, Negrey J, Mace S. "Elderberry Extract Outpatient Influenza Treatment for Emergency Room Patients Ages 5 and Above: a Randomized, Double-Blind, Placebo-Controlled Trial." Journal of General Internal Medicine, 2020;35(11):3271–3277. PMID 32869150.
- Hawkins J, Baker C, Cherry L, Dunne E. "Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta-analysis of randomized, controlled clinical trials." Complementary Therapies in Medicine, 2019;42:361–365. PMID 30670267.
- Singh M, Das RR. "Zinc for the common cold." Cochrane Database of Systematic Reviews, 2015;(4):CD001364. PMID 25924708.
Reviewed against 6 peer-reviewed sources.